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Lipocalin 2 modulates the cellular response to amyloid
beta
SD Mesquita1,2, AC Ferreira1,2, AM Falcao1,2, JC Sousa1,2, TG Oliveira1,2, M Correia-Neves1,2, N Sousa1,2, F Marques*,1,2,3
and JA Palha1,2,3
The production, accumulation and aggregation of amyloid beta (Ab) peptides in Alzheimer’s disease (AD) are influenced by
different modulators. Among these are iron and iron-related proteins, given their ability to modulate the expression of the
amyloid precursor protein and to drive Ab aggregation. Herein, we describe that lipocalin 2 (LCN2), a mammalian acute-phase
protein involved in iron homeostasis, is highly produced in response to Ab1-42 by choroid plexus epithelial cells and astrocytes,
but not by microglia or neurons. Although Ab1-42 stimulation decreases the dehydrogenase activity and survival of wild-type
astrocytes, astrocytes lacking the expression of Lcn2 are not affected. This protection results from a lower expression of the
proapoptotic gene Bim and a decreased inflammatory response. Altogether, these findings show that Ab toxicity to astrocytes
requires LCN2, which represents a novel mechanism to target when addressing AD.
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One of the pathological hallmarks of Alzheimer’s disease (AD)
is the increased production and accumulation of amyloid beta
(Ab) peptides in the brain, which result from the misprocessing
of the membrane amyloid precursor protein. Through an
unidentified combination of events, Ab peptides, initially
soluble, aggregate into oligomers, which are highly toxic to
brain cells. Oligomers of Ab ultimately deposit in different
brain regions and form amyloid plaques.1 The steps that drive
the amyloidogenic pathway are still unclear, but the aggrega-
tion of Ab into dimers, trimers and other toxic oligomeric forms
seems to be decisive. This process was shown to be
influenced by many factors, among which is iron, described
to favor the formation and stabilization of toxic Ab oligo-
mers.2,3 Notably, iron accumulates with age in brain areas that
are preferentially affected in AD patients, such as the
hippocampus and the cortex.4 In these areas, iron and iron-
binding proteins were shown to accumulate in the amyloid
plaques.5 Interestingly, recent evidence points to alterations
in the level of iron metabolism-related proteins, such as
ferritin, and their impact on iron homeostasis as probable
causes of increased amyloid precursor protein expression
and misprocessing, as well as increased aggregation of Ab
into toxic oligomers.6,7
Recently, the iron-associated protein lipocalin 2 (LCN2)
was implicated in AD.8 LCN2, a member of the lipocalin family
of soluble proteins, was originally identified as a constituent of
granules in human neutrophils.9 It was first described as an
acute-phase protein10 able to bind and sequester bacterial
iron-loaded siderophores, thus preventing the growth and
dissemination of the infectious agents.11 In addition, LCN2
has been described also to mediate transferrin-independent
iron delivery12,13 and removal from cells,14 which is asso-
ciated with cell proliferation and apoptosis, respectively.
Although the pathway through which LCN2 influences cell
proliferation remains uncertain, LCN2-mediated apoptosis
involves the proapoptotic protein BCL2-like 11 (BCL2L11 or
BIM).14,15 Of notice, different cells from the central nervous
system (CNS), namely choroid plexus (CP) epithelial cells and
astrocytes, have been shown to produce LCN2 in response to
various stimuli.15–19 Importantly, a recent study demonstrated
that LCN2, produced in response to tumor necrosis factor
(TNF), is able to interfere with TNF receptor protective
signaling and to enhance the toxicity of glutamate and Ab.8
The present study investigated the mechanism through which
LCN2 contributes to the modulation of brain cell metabolism
and survival in response to Ab.
Results
CP epithelial cells overexpress Lcn2 in response
to Ab1-42. Incubation of rat CP epithelial cells with Ab1-42
induced the expression of Lcn2, specifically 48 h after
incubation with 1 mM Ab1-42. Incubation with a lower
concentration of Ab1-42, 0.1mM, for 24 and 48 h did not
influence the expression of Lcn2 (Figure 1a). The expression
of the genes encoding for the receptors of LCN2 (the solute
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carrier family 22 member 17 (Slc22a17 or 24p3r) and the
low-density lipoprotein-related protein 2 (Lrp2); Figure 1b),
for the iron metabolism-related proteins, heme oxygenase 1
(Hmox1) and ferritin heavy chain 1 (Fth), as well as the
expression of the proapoptotic gene Bim (Figures 1c–e)
was also induced by 1 mM Ab1-42. The alteration in Lcn2
expression resulted in increased percentage of cells
co-expressing LCN2 and transthyretin (TTR), a CP epithelial
cell-specific marker (Figures 1f and g).
Astrocytes produce and secrete LCN2 in response to
Ab1-42. As early as 24 h after incubation with 1 mM Ab1-42,
cultured astrocytes isolated from rat brain cortex,
which were Z95% positive for the specific astrocyte
marker glial fibrillary acidic protein (GFAP), presented an
overexpression of Lcn2, and of its receptors, 24p3r and
Lrp2 (Figure 2a). Notably, accompanying the upregulation
in gene expression, an increased oligomerization of
Ab1-42 was observed from 24 h onwards (Supplementary
Figure 1). Double staining for GFAP and LCN2 (Figure 2b)
and for CD11b, a specific marker for microglia present in
these cultures, and LCN2 (Figure 2c) showed intracellular
LCN2 labeling in GFAPþ cells, but not in CD11bþ cells,
upon Ab1-42 stimulation. In accordance, the percentage of
Figure 1 CP epithelial cells express Lcn2 in response to Ab1-42. (a) Lcn2 mRNA level was measured in cultures of rat CP epithelial cells at 24 and 48 h after incubation with
vehicle (control, red line) or different dosages of Ab1-42 (0.1 or 1mM). Lcn2 expression was significantly increased only with 1 mM Ab1-42 at 48 h. (b) The expression of Lcn2
and of the genes that encode for its receptors (24p3r and Lrp2) was found significantly upregulated at 48 h of incubation with 1 mM Ab1-42 in comparison with the respective
time-point controls. (c–e) The expression of Hmox1 (c) was found significantly upregulated at 24 h of incubation with 1 mM Ab1-42, whereas the expression of Fth (d) and Bim
(e) was upregulated only at 48 h. (f) CP epithelial cells were stained for DAPI (blue) and with antibodies for TTR (red) and LCN2 (green). A clear increase in LCN2 production
was observed in Ab1-42-treated cells. (g) The quantification of LCN2
þTTRþ CP epithelial cells revealed that after treatment with Ab1-42 for 48 and 72 h there was a significant
increase in the percentage of double-positive cells, when compared with the respective time-point controls. Results are presented as mean±S.E.M. (NZ4/group; a–g) and
are representative of three independent experiments. Scale bars¼ 100 mm. *Po0.05 and **Po0.01 versus control; ANOVA with Tukey’s multiple comparison test
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LCN2þGFAPþ cells significantly increased, reaching a
peak at 48 h (Figure 2d), as well as the amount of LCN2
secreted by these cells (Figure 2e). LCN2 was secreted by
astrocytes both in response to Ab1-42 and to bacterial
lipopolysaccharide (LPS), a well-known inducer of the
expression of Lcn218 that was used as control (Figure 2f).
Of notice, when Ab1-42 was used to stimulate microglia-
enriched cultures, no LCN2 production was observed (data
not shown).
Treatment with 1 mM Ab1-42 did not influence the expression
of Lcn2 in neuronal-enriched primary cultures from the mouse
brain (Figure 3a); whereas a significant overexpression of
24p3r and a decreased expression of Lrp2was observed after
incubating neurons with Ab1-42 for 48 h (Figure 3a). Western
blot quantification of protein extracts from cultured mouse
astrocytes or neurons exposed to Ab1-42 for 48 and 72 h
showed that LCN2 is highly produced by astrocytes but not by
neurons (Figure 3b). Using beta III-tubulin (bIII-TUB) as a
Figure 2 LCN2 is produced by cultured astrocytes in response to Ab1-42. (a) Lcn2, 24p3r and Lrp2 expression levels were measured in astrocytes cultured with 1mM Ab1-42
for 12, 24, 48 or 72 h and compared with the respective time-point controls (red line). Gene expression was significantly increased 24 h after the incubation with 1 mM Ab1-42
and presented a progressive decrease until it reached control levels at 72 h. (b) Astrocytes treated with vehicle (control) or with 1mM Ab1-42 for 48 h were stained for DAPI
(blue) and with antibodies for GFAP (red) and LCN2 (green). (c) Microglia, found in the astrocyte-enriched cultures, stained positively for the specific marker CD11b (red), but
not for LCN2 (green). (d) A significant increase in the percentage of LCN2þGFAPþ astrocytes was observed after treatment with Ab1-42 for 24, 48 and 72 h, when compared
with the respective time-point controls. (e) LCN2 protein was found to be increased in the culture supernatant of Lcn2(þ /þ ) astrocytes 24, 48 and 72 h after incubation with
1mM Ab1-42, when compared with the supernatant of vehicle-treated Lcn2(þ /þ ) astrocytes (Co). (f) LCN2 protein was secreted by Lcn2(þ /þ ) astrocytes in response to
incubation with 1 mM Ab1-42 or with 100 ng/ml LPS, whereas no LCN2 was detected in the supernatant of Lcn2( / ) astrocytes. Results are presented as mean±S.E.M.
(NZ4/group; a and d) and are representative of two (b–f) or three (a) independent experiments. Scale bars¼ 25mm. *Po0.05 and **Po0.01 versus control; ANOVA with
Tukey’s multiple comparison test
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specific marker for neuronal cells, once again, no LCN2þbIII-
TUBþ cells were observed 72 h after incubation with vehicle
(Figure 3c), LPS (Figure 3d) or Ab1-42 (Figure 3e). However,
we found cells that did not express bIII-TUB and stained
positively for LCN2. These cells, which represented o5% of
the total cells in culture, were GFAPþ astrocytes producing
LCN2 72 h after stimulation with LPS (Figure 3g) or Ab1-42
(Figure 3h).
Lcn2( / ) astrocytes present higher dehydrogenase
activity and survival in response to Ab1-42. To investigate
whether LCN2 produced in response to 1 mM Ab1-42 was
protective or detrimental, we further investigated the cellular
dehydrogenase activity and survival of CP epithelial cells,
astrocytes and neurons, isolated from the brains of Lcn2
(þ /þ ) and of Lcn2( / ) mice, upon in vitro stimulation.
The cellular dehydrogenase activity was measured by the
ratio between the absorbance value relative to tetrazolium
reduction and the total number of cells. The response to
100 ng/ml LPS, which induces the secretion of LCN2 and
influences the cellular dehydrogenase activity and the
survival of astrocytes, but not of neurons,20 was used as
positive control. No differences on the basal activity of
dehydrogenases were observed between brain cells isolated
from Lcn2(þ /þ ) and those isolated from Lcn2( / ) mice
(Supplementary Figures 2A–C). Regardless of the cell’s
genotype, neither Ab1-42 nor LPS influenced the activity of
dehydrogenases of CP epithelial cells when compared with
the respective genotype control (Supplementary Figure 3).
On the contrary, Lcn2(þ /þ ) astrocytes presented a
significant decreased dehydrogenase activity, 48 h after
treatment with Ab1-42 or with LPS, when compared with the
respective genotype control; an effect that was more
pronounced at 72 h (Figure 4a). Interestingly, at 48 and
Figure 3 Neurons do not produce LCN2 in response to Ab1-42. (a) Lcn2, 24p3r and Lrp2 expression levels were measured in primary cultures of neurons isolated from
P0-P1 mice cortices, treated with 1mM Ab1-42 for 24, 48 or 72 h and compared with the respective time-point controls (red line). (b) Western blot analysis of protein extracts
from cultured neurons or astrocytes treated with vehicle (Co) or Ab1-42 for 48 and 72 h showed that only astrocytes produce LCN2. The ratio between the intensity of the bands
of LCN2 and b-actin confirmed the high levels of intracellular LCN2 only in astrocytes treated with Ab1-42. (c–h) Cultured neurons were treated with vehicle (c and f), 100 ng/ml
LPS (d and g) or 1 mM Ab1-42 (e and h) for 72 h. Immunocytochemical staining using DAPI (blue) and specific antibodies for LCN2 (green) and bIII-TUB (c–e) or GFAP (f–h)
(red) showed that onlyo5% of total cells, specifically GFAPþ astrocytes, were producing LCN2 in response to LPS and Ab1-42. Results are representative of two (a, c–h) or
three (b) independent experiments. Scale bars¼ 50mm. *Po0.05 and **Po0.01 versus control; ANOVA with Tukey’s multiple comparison test
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72 h, the percentage of dehydrogenase activity of Lcn2( / )
astrocytes was significantly higher than that of Lcn2(þ /þ )
cells submitted to the same treatments; noticeably, the
dehydrogenase activity of Lcn2( / ) astrocytes increased
48 h after incubation with Ab1-42 or LPS and reached control
levels after 72 h (Figure 4a). We next questioned whether the
previous differences in cellular dehydrogenase activity were
correlated with increased cell death (Figures 4b and c). Both
treatments, with 1 mM Ab1-42 or 100 ng/ml LPS, increased the
percentage of dead Lcn2(þ /þ ) astrocytes at 72 h, when
compared with vehicle-treated Lcn2(þ /þ ) astrocytes
(Figure 4c). Moreover, after incubation with Ab1-42 or LPS
for 72 h, the percentage of dead Lcn2(þ /þ ) astrocytes was
significantly higher when compared with that of Lcn2( / )
astrocytes (Figure 4c). Treatments did not affect Lcn2( / )
astrocytes (Figure 4c).
Neurons from both genotypes, Lcn2(þ /þ ) and Lcn2( / ),
were equally affected by 1mM Ab1-42, which decreased
neuronal dehydrogenase activity (Figure 4d) and increased
the percentage of dead cells 72 h after incubation
(Figures 4e and f). Unexpectedly, incubation with 100 ng/ml
LPS, described not to influence neuronal dehydrogenase
activity,20 induced a decrease in the activity of dehydrogenases
of Lcn2( / ) neurons, but did not affect Lcn2(þ /þ ) neurons
(Figure 4d); yet this effect did not translate into an increased
percentage of dead Lcn2( / ) neurons (Figure 4f).
LCN2 modulates the expression of Bim, iron- and
inflammation-related genes in astrocytes. We next
explored possible mechanisms linking higher production
and secretion of LCN2 to increased Ab1-42 toxicity. As
LCN2 is known to induce apoptosis through the over-
expression of the proapoptotic gene Bim,14 we next analyzed
the expression of Bim in rat astrocytes treated with 1mM Ab1-42.
Bim expression was upregulated 24 h after incubation with
Ab1-42 and returned to basal levels at 72 h (Figure 5a).
As mentioned before, CP epithelial cells also presented
Bim overexpression after 48 h of incubation with Ab1-42
(Figure 1e), nevertheless this increased expression did not
translate into changes in cellular dehydrogenase activity
(Supplementary Figure 3). Given that BIM exerts its
proapoptotic effect by interacting with anti-apoptotic proteins
located in the mitochondria,21 we next quantified the
percentage of astrocytes that presented co-localization of
the mitochondrial marker MitoTracker (MitoT) and BIM. We
observed a time-dependent progressive increase in the
percentage of cells that presented BIM and MitoT
co-localization (Figures 5b and c). To further investigate
the mechanism responsible for the increased susceptibility of
Lcn2(þ /þ ) astrocytes to Ab1-42, we next measured the
expression of iron-related and proinflammatory genes. As
seen in rat astrocytes (Figure 2a), mice Lcn2(þ /þ )
astrocytes similarly presented a significant increase in Lcn2
expression 24 and 48 h after incubation with 1mM Ab1-42
(Figure 5d). Treatment equally induced the expression of
24p3r in Lcn2(þ /þ ) and Lcn2( / ) astrocytes (Figure 5e),
but had no effect on the expression of Hmox2 (Figure 5i). Of
notice, Ab1-42 induced the expression of Lrp2, Bim, Hmox1,
Fth, Il6 and chemokine (C-X-C motif) ligand 10 (Cxcl10) only
in Lcn2(þ /þ ) astrocytes (Figures 5f–h and j–l).
Figure 4 Ab1-42 differentially affects the activity of cellular dehydrogenases and survival of Lcn2(þ /þ ) and of Lcn2( / ) astrocytes and neurons. (a) 1 mM Ab1-42 and
100 ng/ml LPS induced a decrease in the dehydrogenase activity of Lcn2(þ /þ ) astrocytes (black bars) when compared with vehicle-treated cells from the same genotype
(control, red line). Lcn2( / ) astrocytes (dashed bars) presented a higher dehydrogenase activity, 48 or 72 h after treatment with Ab1-42 and LPS, when compared with
Lcn2(þ /þ ) astrocytes. (b) The number of live (green) and dead (red) Lcn2(þ /þ ) or Lcn2( / ) astrocytes was assessed 72 h after treatment with vehicle (control), Ab1-
42 or LPS. Treatment of astrocytes with 30% H2O2 was used as positive control for cell death. (c) Lcn2(þ /þ ) astrocytes are more susceptible to the toxic effects of Ab1-42 and
LPS, as shown by the increased percentage of dead cells in comparison with Lcn2( / ) astrocytes. (d) The dehydrogenase activity of Lcn2(þ /þ ) and Lcn2( / )
neurons decreased equally at 72 h after treatment with Ab1-42, whereas LPS affected the dehydrogenase activity of Lcn2( / ) neurons only. (e) The number of live (green)
and dead (red) Lcn2(þ /þ ) or Lcn2( / ) neurons was assessed 72 h after treatment with vehicle (control), Ab1-42 or LPS. Treatment of neurons with 30% H2O2 was used
as positive control for cell death. (f) Despite the higher percentage of dead neurons after treatment with Ab1-42, no differences were observed between the percentages of dead
Lcn2(þ /þ ) neurons and of dead Lcn2( / ) neurons, after stimulation with Ab1-42 or LPS. Results are presented as mean±S.E.M. (NZ4/group) of percentage increase
of the corresponding genotypes and are representative of two (b–f) or four (a) independent experiments. Scale bars¼ 50mm. *Po0.05 and **Po0.01 versus control;
#Po0.05 and ##Po0.01 versus Lcn2( / ); ANOVA with Tukey’s multiple comparison test
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Exogenous LCN2 leads to death of astrocytes. Astro-
cytes isolated from Lcn2( / ) mice were shown to be
resilient to Ab1-42 toxicity. To assess if this protection could
be reverted, exogenous LCN2 alone or combined with Ab1-42
was added to the culture medium supernatant of astrocytes.
Lcn2(þ /þ ) or Lcn2( / ) astrocytes were treated for 72 h
with vehicle, 1 mM Ab1-42 alone, 100 ng/ml LCN2 alone or
1mM Ab1-42 plus 100 ng/ml LCN2 (Figures 6a and b). Once
again, incubation with 100 ng/ml LPS was used as a positive
control for LCN2 production by Lcn2(þ /þ ) astrocytes. All
treatments resulted in increased percentage of dead
Lcn2(þ /þ ) astrocytes (Figures 6a and b). Notably, LCN2,
alone or combined with Ab1-42, was able to significantly
increase the percentage of dead Lcn2( / ) astrocytes,
Figure 5 Expression of Bim, inflammatory and iron-related genes in Lcn2(þ /þ ) and Lcn2( / ) astrocytes is differentially modulated by Ab1-42. (a) mRNA level of Bim
was increased in rat astrocytes 24 h after incubation with Ab1-42. (b) Astrocytes were stained with a mitochondrial marker, MitoT (red), with a specific antibody for BIM (green)
and with DAPI (blue). Increased BIM staining was observed after incubation with Ab1-42. (c) Ab1-42 induced a significant and progressive increase in the percentage of
astrocytes that presented MitoT and BIM co-localization 24, 48 and 72 h after incubation. (d–l) Lcn2 expression (d) was significantly upregulated in mouse Lcn2(þ /þ )
astrocytes (black bars), 24 and 48 h after incubation with Ab1-42, when compared with the respective time-point control (red line). No Lcn2 expression was detected in
Lcn2( / ) astrocytes (dashed bars). Except for 24p3r (e) and Hmox2 (i), Ab1-42 induced an increase in the mRNA levels of Lrp2 (f) Bim (g), Hmox1 (h), Fth (j), Il6 (k) and
Cxcl10 (l) in Lcn2(þ /þ ) astrocytes, but not in Lcn2( / ) astrocytes. Results are presented as mean±S.E.M. (NZ5/group) and are representative of two (b and c) or
three (a, d–l) independent experiments. Scale bars¼ 25mm. *Po0.05 and **Po0.01 versus control; #Po0.05 and ##Po0.01 versus Lcn2( / ); ANOVA with Tukey’s
multiple comparison test
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when compared with control cells, whereas Ab1-42 alone or
LPS alone were not (Figure 6a).
Discussion
Herein, we provide evidence for a novel role of LCN2 as a
mediator of Ab cytotoxicity. Specifically, we show that
incubation with Ab1-42 induces the expression of Lcn2, and
its secretion, by CP epithelial cells and by astrocytes, but not
by microglia or neurons, isolated from the brain of both rats
and mice. Moreover, we show that Ab1-42 significantly reduces
the dehydrogenase activity and survival of astrocytes that
produce LCN2, an effect that is abrogated in astrocytes from
Lcn2( / ) mice. The protection of Lcn2( / ) astrocytes to
Ab1-42-mediated toxicity is lost by the addition of exogenous
LCN2.
We addressed the role of LCN2 in Ab toxicity by studying
the response of four cell types: CP epithelial cells, astrocytes,
microglia and neurons. CP epithelial cells constitute, in vivo,
the blood–cerebrospinal fluid (CSF) barrier and produce most
of the constituents of the CSF. Importantly, CP epithelial cells
are also involved in the excretion of Ab out of the brain through
different pathways.22,23 One of these pathways is mediated by
LRP2, which is expressed by CP epithelial cells and was
shown to lead to Ab internalization and removal from the CSF
in a mouse model of AD.24 Here we show that, despite the
increased production of LCN2 protein after stimulation with
Ab1-42, CP epithelial cells seem to deal with the toxicity caused
by these peptides, through mechanisms that deserve further
investigation.
Astrocytes, the most abundant cells in the brain, interact
with neurons and regulate neuronal homeostasis,25 through
the secretion of several molecules, including LCN2.26
Production of LCN2 by astrocytes was previously described
both in vitro, in response to proinflammatory cytokines such as
interferon-g and TNF,17,26 and in vivo, in models of CNS
neuroinflammatory diseases like experimental autoimmune
encephalomyelitis19 and spinal cord injury.27 Interestingly,
also microglial cells were shown to respond to LCN2, which
seems to favor their polarization into a M1-activated pheno-
type.28 Here, we show that LCN2 is not produced by microglia
in response to Ab1-42, both in astrocyte-enriched cultures
(o5% microglia) and in microglia-enriched cultures.
Given that neurodegeneration is a critical feature of AD and
that neurons are highly sensitive to monomeric/dimeric Ab1-42
toxicity,1,29 we also studied neurons. We clearly show that,
in vitro, Lcn2 expression is not altered in neurons and that
LCN2 protein is not produced by these cells, neither in basal
conditions nor in response to LPS or Ab1-42. Others have
suggested that, in vitro, LCN2 is produced by neurons in
response to TNF8 or to the less toxic Ab1-40 peptide
30 and,
in vivo, by neurons from the hippocampus of mice submitted to
acute stress.31 This discrepancy may be related to the
different stimuli studied or to neuron-enriched culture
Figure 6 Exogenous LCN2 alone or together with Ab1-42 induces an increase in the percentage of dead astrocytes. (a) The percentage of dead Lcn2(þ /þ ) astrocytes
(black bars) increased significantly after 72 h of incubation with 1 mM Ab1-42, 100 ng/ml LCN2, Ab1-42 plus LCN2 or with 100 ng/ml LPS. In response to the same treatments,
the percentage of dead Lcn2( / ) astrocytes (dashed bars) was only increased in response to LCN2 or Ab1-42 plus LCN2. (b) Representative images of live (green) and
dead (red) Lcn2(þ /þ ) or Lcn2( / ) astrocytes after treatment with Ab1-42, LCN2, Ab1-42 plus LCN2 or LPS for 72 h. Treatment of astrocytes with 30% H2O2 for 1 h was
used as positive control for cell death. Results are presented as mean±S.E.M. (NZ4/group) of percentage increase. Scale bars¼ 25mm. **Po0.01 versus control;
##Po0.01 versus Lcn2( / ); ANOVA with Tukey’s multiple comparison test
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contamination by astrocytes that can easily proliferate in
culture, even after treatment with inhibitors of cellular
proliferation. In accordance, we observed that a small
percentage of astrocytes (o5%) present in the neuronal-
enriched cultures treated with Ab1-42 or LPS, stained
positively for LCN2. Of relevance and concomitant to our
observations, a recent study states that, in the brain, only
reactive astrocytes are able to produce LCN2 and that, when
secreted, this protein is a potent mediator of neurotoxicity.26
Importantly, in response to Ab1-42, LCN2 appears to
mediate the overexpression of proinflammatory and iron-
related genes in astrocytes, favoring the already described
neurotoxic phenotype.32 One of these genes encodes for the
proinflammatory cytokine interleukin-6 (IL-6), which is highly
expressed by Lcn2(þ /þ ) astrocytes in response to Ab1-42,
supporting previous observations upon treatment with
Ab1-40.
33 The implication of LCN2 in this process stems from
the observation that Ab1-42 is not able to upregulate Il6
expression in Lcn2( / ) astrocytes. This regulatory loop
between LCN2 and IL-6 seems to happen in both directions,
as others have observed that Il6( / ) mice injected with
LPS present a lower expression of Lcn2 in the hypothalamus
when compared with Il6(þ /þ ) mice.34 Similarly, the expression
of Il6 and Cxcl10 was upregulated in Lcn2(þ /þ ) astrocytes,
but not in Lcn2( / ) astrocytes, in response to Ab1-42. Previous
studies have shown that different cell populations from the
CNS are able to upregulate the expression of Cxcl10 after
treatment with LCN2, which, in turn, promotes the activation
and migration of glial cells within the CNS.16,28 Moreover,
Ab1-42 led to an overexpression of Hmox1 and Fth in CP
epithelial cells and in astrocytes. It is well established that both
CP epithelial cells and astrocytes have an important role in
brain iron metabolism and changes in the expression of iron-
related genes are often correlated with alterations in the level
of intracellular/extracellular iron ratio under stressful condi-
tions.35,36 Of relevance, we show that the changes observed
in the expression of Hmox1 and Fth in response to Ab1-42 are
abrogated in Lcn2( / ) astrocytes, suggesting that signal-
ing through LCN2 may directly or indirectly regulate the
expression of genes involved in iron metabolism. Ultimately,
high levels of extracellular LCN2, secreted by CP epithelial
cells or astrocytes in response to Ab1-42, can also impact on
the level of extracellular iron, thus promoting the formation
and stabilization of toxic Ab intermediates2 and increase the
level of oxidative and mitochondrial damage in brain cells.37,38
Also of relevance, LCN2 produced in response to Ab1-42 led
to dehydrogenase dysfunction and increased apoptosis.
Others have shown that LCN2 is an autocrine mediator of
astrocytosis, able to decrease the viability of astrocytes and to
increase the levels of oxidative damage by boosting the
effects of other noxious agents, such as sodium nitroprusside
dihydrate or LPS.17 Mechanistically, it was shown that 24p3R
is able to internalize apo-LCN2, promoting the removal of iron
from cells, which increases the level of BIM and cell
apoptosis.14 This is in agreement with another study,
reporting that apo-LCN2 secreted by astrocytes promotes
neuronal death in a concentration-dependent manner;26 an
effect that seems to be ablated if neurons are incubated with
apo-LCN2 plus iron-siderophore complexes.15 Supporting
these findings, we now show that monomeric/dimeric Ab1-42
increases the expression of 24p3r in astrocytes and neurons.
Therefore, LCN2, secreted in response to Ab1-42 and
internalized through 24p3R, can be an autocrine or paracrine
modulator of brain cell viability, via the iron-responsive
proapoptotic protein BIM (Figure 7). Overexpression of
Lcn2, 24p3r and Lrp2 in Lcn2(þ /þ ) astrocytes is accom-
panied by a progressive and significant decrease in the
activity of cellular dehydrogenases and increased cell death;
which is not observed in Lcn2( / ) astrocytes. This can be
due to a progressive increase of BIM that translocates into the
mitochondria in a process known to culminate in cell
apoptosis.21,39 Notably, the overexpression of Bim is also
regulated by LCN2, given that Bim expression is not induced
in Lcn2( / ) astrocytes upon stimulation with Ab1-42.
Concomitantly, after incubation with Ab1-42 or LPS, the
percentage of dead Lcn2( / ) astrocytes was lower than
that of Lcn2(þ /þ ) astrocytes, which reinforces the view that
in the absence of LCN2 the toxic effects of both Ab1-42 and
LPS are reduced. However, taking into account recent
observations suggesting that LCN2 alone is not able to induce
apoptosis in astrocytes,26 we cannot discard an indirect
modulation of astrocytes’ survival by molecules secreted by
activated microglia (o5% in astrocyte-enriched cultures),
because of their ability to respond to LCN2.28 In fact, others
have shown that in response to LPS, microglia are able to
influence the survival of brain cells, oligodendrocytes in
particular, by secreting proinflammatory molecules like
TNF,40 and that this process is modulated, in vivo, by LCN2.28
Of notice, neuronal apoptosis in response to Ab1-42 is
independent of their ability to produce LCN2 as the survival of
Lcn2(þ /þ ) and Lcn2( / ) neurons significantly decreased
in response to Ab1-42. Nevertheless, we show that 24p3r is
overexpressed by neurons after incubation with monomeric/
dimeric Ab1-42, which means that despite their inability to
produce LCN2, these cells may be able to respond to it.
Whether LCN2 is involved in neuronal overexpression
of Bim, which was shown to mediate apoptosis in response
to Ab1-42,
41 needs to be further investigated.
Our observations clearly support a role for LCN2 as a
modulator of the response of astrocytes to Ab peptides.
Interestingly, LCN2 is an acute-phase protein able to
modulate the expression of key proinflammatory mediators
in glial cells, such as IL-12, IL-23, TNF and inducible nitric
oxide synthase,16 that can ultimately influence glial and
neuronal morphology, migration and also sensitize these
brain cells to oxidative damage and apoptosis.15,17 Of
relevance, the expression of most of these proinflammatory
molecules, including LCN2, can be upregulated through
Toll-like receptor 4,42 which is activated by LPS, but is also
closely involved in the binding of extracellular Ab peptides.43
Toll-like receptor 4 signaling cascades, which are distinct
between glial cells and neurons,44 might also explain the
differences that we observe concerning the production of
LCN2, a topic that warrants further investigation. Accordingly,
it was recently shown that astrocytes isolated from the
brain of Lcn2( / ) mice are unable to express the classical
proinflammatory genes in response to LPS and interferon-g.32
We observed the same kind of gene expression abrogation in
Lcn2( / ) astrocytes after treatment with Ab1-42, which may
denote an anti-inflammatory phenotype that is conferring
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protection in response to these toxic peptides (Figure 7).
Curiously, others have shown that Ab peptides promote
calcium-dependent activation of NADPH oxidase in astro-
cytes, but not in neurons, which is closely associated with
increased neurodegeneration.45 Given this observation, it will
be important to further elucidate on the involvement of Ab-
induced calcium signaling and mitochondrial dysfunction as
triggers for increased LCN2 production and secretion by
astrocytes. Importantly, it has been previously shown that
LCN2 is able to modulate neuronal function, particularly
neuronal excitability, through the modulation of neuronal
spine formation and morphology.31 Thus, produced in
response to Ab1-42, LCN2 can regulate important mechan-
isms and pathways that are critical for brain cell activation31,32
and that may ultimately lead to alterations in brain areas
involved in cognition and memory, which are affected in AD.46
In agreement, patients with mild cognitive impairment present
high levels of LCN2 in the plasma47 and low levels of LCN2 in
the CSF,8 which points to an imbalance of LCN2 levels in the
brain in the early phases of dementia. It is clear, thus, that the
role of LCN2 in neurodegenerative disorders such as AD
warrants further investigation. This study adds an important
piece into the field by showing that LCN2 is required for Ab
toxicity to astrocytes, which becomes a natural target to
modulate in AD.
Materials and Methods
Animal strains and genotyping. Animal handling and experiments were
conducted in accordance with the Portuguese National Authority for Animal
Experimentation, Direc¸a˜o Geral de Veterina´ria (ID:DGV9457). Animals were kept
in accordance with the guidelines for the care and handling of laboratory animals
in the Directive 2010/63/EU of the European Parliament and Council. For cell
culture experiments, Wistar Han rat post-natal day 0 (P0)-P1 pups were used to
perform primary cultures of neurons and P5-P7 pups to perform cultures of
astrocytes, microglia or CP epithelial cells. In addition, Lcn2( / ) mice,48 and
the respective wild-type littermate controls, Lcn2(þ /þ ), raised in a C57BL/6J
background were used.
Primary cultures of CP epithelial cells. CP epithelial cells from rats or
mice pups were used to determine the response to Ab. CP epithelial cells were
prepared as described elsewhere,49 with minor modifications. Briefly, neonates
(P5-P7) were killed and the CP dissected from the four brain ventricles, under a
conventional light microscope (SZX7, Olympus, Hamburg, Germany). The tissue
was rinsed twice in phosphate-buffered saline (PBS, Invitrogen, Carlsbad, CA,
USA) without Ca2þ and Mg2þ , followed by a 25-min digestion with 0.1 mg/ml
pronase (Sigma-Aldrich, St. Louis, MO, USA) at 37 1C. Predigested tissue was
recovered by sedimentation and briefly shaken in 0.025% trypsin-EDTA
(Invitrogen) containing 12.5mg/ml DNAse I (Roche, Amadora, Portugal). The
supernatant was then withdrawn and kept on ice with 10% fetal bovine serum
(FBS, Invitrogen). This step was repeated five times. Cells were pelleted by
centrifugation and re-suspended in culture media consisting of Ham’s F-12 and
Dulbecco’s modified Eagle’s medium (DMEM; 1 : 1; Invitrogen) supplemented with
10% FBS, 2 mM glutamine, 50 mg/ml gentamycin, 5 mg/ml insulin, 5 mg/ml
transferrin, 5 ng/ml sodium selenite, 10 ng/ml epidermal growth factor, 2 mg/ml
hydrocortisone and 5 ng/ml basic fibroblast growth factor (all from Sigma-Aldrich).
For further enrichment, cells were incubated on plastic dishes for 2 h at 37 1C. The
supernatant containing the CP epithelial cells was collected and placed for seeding
on 0.4mm pore size Transwells (Corning Life Sciences, Lowell, MA, USA) coated
with laminin (BD Biosciences, Bedford, MA, USA) at a density of 1 105 cells/cm2.
The culture medium was changed every 2 days and CP epithelial cells were
maintained in culture for 5–7 days, at 37 1C in a humid atmosphere (5% CO2),
before performing the experiment. To assess the purity and confluence, cells were
immunostained with a specific antibody for TTR (kindly provided by Dr. Maria Joao
Saraiva, Institute for Molecular and Cell Biology, Porto, Portugal), a specific
marker of CP epithelial cells.50 Cell counting revealed that Z95% of the cells
stained positive for TTR.
Figure 7 LCN2 is induced by Ab1-42 and modulates cell survival. Lcn2 is one of the genes highly expressed by CP epithelial cells and astrocytes in response to Ab1-42.
This increase is similarly reflected at the LCN2 protein level. Ab1-42 induces the expression of 24p3r and Lrp2, genes that encode for receptors that bind LCN2 and can lead to
its internalization. LCN2 internalization may mediate the increase in proapoptotic BIM and its translocation into the mitochondria. Ultimately, Lcn2(þ /þ ) astrocytes, which
produce and secrete LCN2 in response to Ab1-42, present a decreased viability when compared with Lcn2( / ) astrocytes. Of notice, the production of LCN2 is somehow
mediating the expression of genes involved in iron metabolism and in the proinflammatory response to Ab1-42. It is still unclear if this LCN2-mediated apoptotic mechanism
occurs through alterations in the level of intracellular/extracellular iron ratio. However, these observations strongly suggest that LCN2 participates in the early proinflammatory
response induced by Ab peptides
LCN2 modulates Ab-induced cell toxicity
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Primary cultures of astrocytes. The experimental procedure to obtain
primary cultures of astrocytes from the brain of P5-P7 rats or mice was the same
as described elsewhere, with some modifications.51 Brain macro-dissection was
performed in ice-cold PBS, without Ca2þ and Mg2þ , under a conventional light
microscope (SZX7, Olympus). Briefly, the olfactory bulbs were discarded and the
contaminating CP and meninges were carefully removed. The whole forebrain and
the cortices, including the hippocampus, were cut into smaller fragments and
incubated for 30 min at 37 1C in PBS supplemented with 0.025% trypsin-EDTA
and 12.5mg/ml DNAse I. The digested tissue fragments were washed three times
with DMEM supplemented with 10% FBS, 0.5 mM L-glutamine, 1% sodium
pyruvate (Invitrogen) and 1% penicillin-streptomycin (10 000 units penicillin–10 mg
streptomycin, Sigma-Aldrich) and mechanically dissociated through a 2-ml pipette
and a Pasteur pipette. A single-cell suspension in supplemented DMEM was
obtained and cells were plated on coverslips or culture wells (Nunc, Roskilde,
Denmark) coated with poly-D-lysine (Sigma-Aldrich), at a density of 25 000 cells/cm2.
The culture medium was changed every 2 days and glial cells were maintained in
culture for 5–7 days, at 37 1C in a humid atmosphere (5% CO2). A confluent
monolayer of astrocytes was formed and cells were Z95% positive for GFAP.
Primary cultures of microglia. Microglia-enriched cultures were obtained
as described elsewhere, with some modifications.51 Brain macro-dissection and
cellular dissociation were performed following the same method described for
astrocytes. Briefly, after obtaining a single-cell suspension, 1 106 cells/cm2 were
plated in polystyrene T75 flasks (Thermo Scientific, Fremont, CA, USA), previously
coated with poly-D-lysine (Sigma-Aldrich), and were maintained at 37 1C in a
humid atmosphere (5% CO2) for 2 weeks, in supplemented DMEM, with periodical
medium renewal. After that, the flasks were agitated in an orbital shaker at
240 r.p.m. during 4 h. Following this, the medium containing detached microglia
cells was collected, centrifuged at 1200 r.p.m. for 5 min and the cells were
re-suspended in supplemented DMEM and plated at a density of 40 000 cells/cm2
on coverslips coated with poly-D-lysine (Sigma-Aldrich). Microglial cells (Z95%
positive for CD11b) were then maintained at 37 1C in a humid atmosphere
(5% CO2) until further testing.
Primary cultures of neurons. Primary cultures of neurons were obtained
from the brains of newborn mice (P0-P1) as described elsewhere, with some
modifications.52 Briefly, the olfactory bulbs, meninges and CP were removed from
the whole forebrain and the cortices, including the hippocampus, were dissected
into smaller fragments, trypsinized for 30 min at 37 1C and mechanically
dissociated, following the same method described for glial cells. After that, the
cells were washed five times with Hanks’ balanced salt solution supplemented with
0.5% penicillin-streptomycin (Sigma-Aldrich), 10 mM HEPES solution and 1%
sodium pyruvate (Invitrogen) and re-suspended in minimum essential medium
(Invitrogen) supplemented with 10% FBS, 0.5% glucose (Sigma-Aldrich), 0.5%
penicillin-streptomycin, 2 mM L-glutamine and 1% minimum essential medium
vitamins (Invitrogen). Cells were plated on coverslips or culture wells (Nunc)
coated with poly-L-ornithine (Sigma-Aldrich), at a density of 50 000 cells/cm2 and
left at 37 1C in a humid atmosphere (5% CO2) for 5 h. After this, the medium was
changed into Neurobasal A (Invitrogen) supplemented with 0.5 mM L-glutamine
and 2% B27 (Invitrogen). The culture medium was changed 24 h after for
Neurobasal A with 2% B27, 1% newborn calf serum (Invitrogen), 0.5 mM
L-glutamine, 0.03 mM uridine (Sigma-Aldrich), 0.07mM FDU (Sigma-Aldrich) and
1mM kynurenic acid (Sigma-Aldrich) to prevent the proliferation of cells
undergoing mitotic division and to reduce enhanced synaptic transmission. The
neuronal cells were maintained in culture for at least 15 days, in a humid
atmosphere (5% CO2) at 37 1C, before starting the experiment. After 15 days in
culture, cells were Z95% positive for the neuronal marker bIII-TUB.
Cell treatment. Cells were treated with culture medium alone (vehicle or
control), culture medium with Ab1-42 (American Peptide Company, Sunnyvale, CA,
USA) or culture medium with bacterial LPS (Escherichia coli, serotype O55:B5,
Sigma-Aldrich), after reaching confluence. Ab1-42 was dissolved in Tris-NaCl buffer
(150 mM NaCl and 50 mM Tris-HCl pH 7.4 from Sigma-Aldrich) to a final
concentration of 221.5mM and kept in stock at -80 1C. We chose to use
preparations of soluble monomeric/dimeric Ab1-42 as a cellular stimulator, as this is
expected to mimic the form released by cells into the extracellular milieu.29,53
To stimulate the cells with 0.1 or 1mM monomeric/dimeric Ab1-42, stock Ab1-42
was dissolved in the appropriate culture medium. As shown in Supplementary
Figure 1, during the incubation period these become oligomeric, which again
mimics what seems to occur in vivo.1 Cells were also stimulated with
100 ng/ml LPS or 100 ng/ml LCN2 for 48 or 72 h. Cells incubated with 30%
H2O2 (Panreac Quimica, Cascais, Portugal) were used as positive controls for
cell death.
Gene expression measurements by qRT-PCR. Total RNA was
extracted from cells using the RNeasy Plus Micro Kit (Qiagen, Hamburg,
Germany), following the manufacturer’s instructions. RNA quality and quantifica-
tion was assessed in the NanoDrop ND-1000 (NanoDrop, Thermo Scientific,
Wilmington, DE, USA) and 500 ng of RNA from each sample was reverse
transcribed into cDNA using the iScriptTM cDNA Synthesis Kit (Bio-Rad
Laboratories, Hercules, CA, USA) following the manufacturer’s instructions.
Primers used to measure the expression levels of selected mRNA transcripts of
Rattus norvegicus and of Mus musculus by qRT-PCR were designed using the
Primer3 software,54 on the basis of the respective GenBank sequences. The
reference gene hypoxanthine guanine phosphoribosyl transferase (Hprt) was used
as internal standard for the normalization of the selected transcripts’ expression.
All gene accession numbers and primer sequences are provided in Supplementary
Table 1. Annealing temperatures are available on request. qRT-PCR was
performed on a CFX 96TM real-time system instrument (Bio-Rad Laboratories),
with the QuantiTect SYBR Green RT-PCR reagent kit (Qiagen) according to the
manufacturer’s instructions, using equal amounts of cDNA from each sample. The
cycling parameters were 1 cycle at 95 1C for 15 min, followed by 40 cycles at
94 1C for 15 s, annealing temperature (primer specific) for 30 s and 72 1C for 30 s,
finishing with 1 cycle at 65 1C to 95 1C for 5 s (melting curve). Product
fluorescence was detected at the end of the elongation cycle. All melting curves
exhibited a single sharp peak at the expected temperature.
Immunocytochemistry and fluorescence microscopy. Cells were
fixed in 4% paraformaldehyde at room temperature (RT) for 20 min. If
mitochondrial staining was required, before fixation, the cells were incubated
with MitoTracker Red FM (MitoT, Invitrogen) for 30 min at 37 1C in a humid
atmosphere (5% CO2), according to the manufacturer’s instructions. Cells were
then blocked with PBS 0.3% Triton X-100 (Sigma-Aldrich; PBS-T) with 0.5%
bovine serum albumin (Sigma-Aldrich) for 1 h at RT. The different cell types
were incubated for 1 h at RT with the primary antibodies for TTR (1 : 1000),
GFAP (1 : 500, Dako, Golstrup, Denmark), CD11b (1 : 100, BioLegend, San
Diego, CA, USA), bIII-TUB (1 : 500, Millipore Iberica, Madrid, Spain), LCN2
(1 : 400, R&D Systems, Minneapolis, MN, USA) or BIM (1 : 200, Cell Signaling
Technology, Beverly, MA, USA) diluted in PBS-T. Cells were washed and
incubated with specific Alexa 488-conjugated or Alexa 594-conjugated
secondary antibodies (Invitrogen) diluted in PBS-T (1 : 500) for 1 h at RT,
according to the source and isotype of the primary antibodies. Cells were
washed with PBS and incubated with 40,6-diamidino-2-phenylindole (DAPI,
1 : 1000, Invitrogen) in PBS for 5 min at RT. Finally, cells were washed with
PBS, the glass coverslips were mounted in PermaFluor mounting medium
(Thermo Scientific). Fluorescence analysis and image capture were performed
using a conventional (BX61; Olympus) or a confocal (FV1000; Olympus)
microscope.
Cell counting strategy. The confocal microscope was used to acquire 30
images from random consecutive fields of each glass coverslip (each sample). Ten
images were randomly selected and used for the quantification of total number
(DAPIþ cells), single- or double-positive cells using the Olympus Fluoview
FV1000 software (Olympus). The number of double-positive cells was normalized
to the number of TTRþ cells (for CP epithelial cells), GFAPþ cells (for astrocytes)
or MitoTþ (mitochondrial marker) cells. Increased percentage of double-positive
cells after treatment with Ab1-42 was calculated assuming 100% for the respective
time-point controls.
Western blot for LCN2 and Ab1-42. To assess the presence of cellular
LCN2 protein, total protein was extracted from cells homogenized in suspension
buffer (0.25 M NaCl; 0.05 M Tris–HCl pH 7.6; 2 mM EDTA pH 8.0, 10% glycerol
and complete protease inhibitor cocktail, all from Sigma-Aldrich), followed by
sonication for 3 min. The homogenates were centrifuged at 4 1C for 10 min at
10 000 r.p.m., and the pellet was discarded. Proteins were quantified using the
Bio-Rad protein assay. To assess the degree of Ab1-42 oligomerization or the
presence of LCN2 in the culture medium supernatants, the samples were
concentrated by reducing the total volume of medium to about 1/10 of initial
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volume, using the Thermo/Savant SpeedVac (Artisan Technology Group,
Champaign, IL, USA). The same volume of culture medium (25–40ml) or total
cellular protein (10 mg) from each sample was boiled for 5 min in Laemmli buffer
(4%SDS; 0.12 M Tris–HCl pH 6.8; 20% glycerol and 0.2 M DTT, all from Sigma-
Aldrich), resolved in a 10% (for LCN2) or 12% (for Ab1-42) polyacrylamide gel
(SDS-PAGE) and then transferred to a nitrocellulose membrane. The membrane
was stained with Ponceau S (Sigma-Aldrich) to confirm transfer efficiency. The
membrane was blocked with 5% skim milk (Nestle S.A., Linda-a-Velha, Portugal)
in PBS 0.1% Tween 20 (Sigma-Aldrich) and then probed with mouse anti-human
Ab1-16 (6E10) antibody (1 : 1000, Covance, Madrid, Spain) or goat anti-mouse
LCN2 antibody (1 : 500, R&D Systems) in 2.5% skim milk in PBS 0.1% Tween 20.
Goat anti-mouse IgG-HRP (1 : 5000, Santa Cruz Biotechnology, Santa Cruz, CA,
USA) or donkey anti-goat IgG-HRP (1 : 10 000, Santa Cruz Biotechnology) in PBS
0.1% Tween 20 was employed as secondary antibodies for Ab1-16 and LCN2,
respectively. The blot was developed using the Clarity Western ECL Substrate
(Bio-Rad Laboratories) and exposed to X-ray film (Amersham, Uppsala, Sweden).
If necessary, the membrane was also blotted with anti-mouse b-actin antibody
(1 : 100, Santa Cruz Biotechnology) to normalize for cellular protein load. Ratio
between the intensity of the bands of LCN2 and b-actin was measured using the
image processing software ImageJ (Bethesda, MD, USA).
Measurement of cellular dehydrogenase activity and viability.
Dehydrogenase activity of CP epithelial cells, astrocytes and neurons was
measured using the CellTiter 96 AQueous One Solution Cell Proliferation Assay
(Promega, Madison, WI, USA), according to manufacturer’s instructions. Briefly,
after the different treatments, cells were washed, first with PBS and then with
DMEM, and incubated with the tetrazolium compound diluted in DMEM (1 : 5)
for a period of 2–3 h, at 37 1C in a humidified atmosphere (5% CO2). The
degree of conversion of tetrazolium into the formazan product by viable cells is
considered a surrogate marker of the cellular dehydrogenase activity.55
Following this incubation period, culture medium of each culture well was
distributed in triplicates in a 96-well plate and the absorbance was read at
490 nm. Absorbance values were divided by the number of DAPI-positive nuclei
in the corresponding cell culture well, giving us a measure of the cellular
metabolism of tetrazolium into formazan. To calculate the differences in
dehydrogenase activity between the control and Ab1-42 or control and LPS
groups, the normalized absorbance values obtained for the vehicle-treated cells
(of each genotype) at 48 or 72 h, were defined as 100% of dehydrogenase
activity. Cell viability was assessed using the LIVE/DEAD Viability/Cytotoxicity
Kit (Invitrogen), according to the manufacturer’s instructions. Briefly, cells from
each well were washed with PBS and incubated with 2mM of ethidium
homodimer-1 and 0.5mM of the polyanionic dye calcein in PBS for 45 min at RT,
protected from light. Cells were then washed with PBS and stained with DAPI for
5 min at RT. Finally, cells were washed with PBS, fixed with 4% paraformaldehyde
at RT for 20 min, washed with PBS, mounted with glass coverslips in PermaFluor
mounting medium and kept at 4 1C in the dark until further use. Alive cells
incorporated calcein and emitted green fluorescence (517 nm), whereas ethidium
homodimer-1 was incorporated in the nucleus of dead cells and emitted red
fluorescence (617 nm). The number of fluorescent live and dead cells was counted
and the percentage of dead cells was determined.
Statistical analysis. Values are reported as means±standard error
(S.E.M.). Each condition was tested at least in triplicates in each independent
experiment and the number of independent experiments is specified in the
legend of each Figure. Statistical significant differences between groups were
determined using one-way ANOVA, followed by Tukey’s multiple comparison
test. Values were considered to be statistically significant for Po0.05 (* or #)
and Po0.01 (** or ##).
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